BI
VYGR icon

BVF Inc’s Voyager Therapeutics VYGR Stock Holding History

BVF Inc’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-140,000
Closed -$827K – 83
2022
Q2 		$827K Sell
140,000
-1,049,100
-88% -$7.09M 0.04% 76
2022
Q1 		$9.06M Buy
1,189,100
+1,166,900
+5,256% +$5.21M 0.36% 58
2021
Q4 		$60K Buy
+22,200
New +$75.7K ﹤0.01% 83
2019
Q2 		– Sell
-310,299
Closed -$5.94M – 58
2019
Q1 		$5.94M Buy
+310,299
New +$4.04M 0.67% 39

Other funds holding VYGR

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BVF Inc's VYGR Position: Q3 2022 in Review

BVF Inc sold out of Voyager Therapeutics (VYGR) in Q3 2022, closing a stake of 140,000 shares — an estimated $827K sold.

BVF Inc first reported a position in VYGR in Q1 2019 and held it in 4 quarters. The position peaked at $9.06M in Q1 2022. 69 funds tracked by Wall St. Rank hold VYGR as of Q3 2022.

  • BVF Inc reported no remaining Voyager Therapeutics position as of Q3 2022 after selling out during the quarter.
  • BVF Inc sold 140,000 Voyager Therapeutics shares in Q3 2022, an estimated $827K.
  • BVF Inc first reported a position in Voyager Therapeutics in Q1 2019 and held it in 4 quarters.
  • BVF Inc's Voyager Therapeutics position peaked at $9.06M in Q1 2022.
  • 69 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2022.

Based on BVF Inc's 13F filing for Q3 2022, filed 14 Nov 2022.